Crealife Technology

Crealife Medical Technology is a China-based medical device company specializing in the development and commercialization of minimally invasive solutions for cardiovascular diseases. The company focuses on structural heart disease, electrophysiology, and vascular interventions, with a portfolio that includes transcatheter aortic valve replacement (TAVR) systems and radiofrequency ablation catheters. Crealife aims to provide high-quality, affordable interventional devices to address the growing burden of heart disease in China and globally. Their products are designed to simplify complex procedures and improve patient outcomes through innovative engineering. The company's flagship C-Valve system has received regulatory approval in China, marking a significant milestone in their commercial expansion.